ARX aroa biosurgery limited

News: ARX Aroa Biosurgery Maintains FY25 Normalised EBITDA Profit Guidance

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 24 (Reuters) - Aroa Biosurgery Ltd (ARX) :

    • FY25 NORMALISED EBITDA PROFIT GUIDANCE MAINTAINED
    • FY25 REVENUE GUIDANCE MAINTAINED AT NZ$80-87 MILLION

    (([email protected];))

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
69.5¢
Change
0.025(3.73%)
Mkt cap ! $239.7M
Open High Low Value Volume
69.5¢ 69.5¢ 66.5¢ $227.2K 337.3K

Buyers (Bids)

No. Vol. Price($)
1 16000 66.0¢
 

Sellers (Offers)

Price($) Vol. No.
69.5¢ 2363 1
View Market Depth
Last trade - 16.10pm 18/09/2025 (20 minute delay) ?
ARX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.